학술논문
Pre-existing interstitial lung abnormalities are independent risk factors for interstitial lung disease during durvalumab treatment after chemoradiotherapy in patients with locally advanced non-small lung cancer.
Document Type
Journal
Author
Daido, Wakako; Masuda, Takeshi; Imano, Nobuki; Matsumoto, Naoko; Shoda, Hiroyasu; Hamai, Kosuke; Iwamoto, Yasuo; Takayama, Yusuke; Mishima, Shohei; Masuda, Ken; Kawase, Shigeo; Awaya, Yoshikazu; Nishimura, Yoshifumi; Shiota, Naoki; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Kitaguchi, Soichi; Fujitaka, Kazunori; Nagata, Yasushi; Hattori, Noboru
Source
Subject
Language
English
ISSN
15277755